In light of the recent temporary suspension of Novartis vaccine products (Agriflu and Fluad), Interior Health wishes to advise the public that our public flu clinics will continue as scheduled using our primary vaccine product Vaxigrip.
Novartis products comprise less than 10 per cent of the vaccine supply in Interior Health. Interior Health has been using another vaccine product for the majority of this year’s influenza vaccination campaign that is not affected by the suspension. This product will also continue to be available through community vaccine providers such as doctors and pharmacists.
On Oct. 26, Health Canada issued a voluntary suspension of the use of Novartis influenza vaccines due to the presence of small particles found in the vaccines in Europe. The suspension is a precautionary measure. B.C. has temporarily suspended the use of these vaccine products.
The public can be assured that all lots of the Novartis vaccines received in B.C. had passed Health Canada’s inspection systems with no concerns and that there have been no reports in Canada or internationally of any increased side effects or health problems from the Novartis vaccines.
For information on the influenza vaccine and to find a flu clinic near you visit: www.interiorhealth.ca/FluClinics